New Drug Update 2020, part 1

Subject areas

This course counts toward the state boards and subject areas below.

Disclosure statements

Learning Objectives:

At the conclusion of this session, the participant will be able to:

1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts.
2. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.
3. Describe their adverse effects and drug interaction that may affect patient compliance.
4. Compare efficacy, dosage and cost to existing agents.
5. Discuss the patient oriented outcomes or evidence that may or may not exist for each of the new medications and when they may or may not be appropriate to recommend for selected patients.
6. Compare pharmacotherapy outcomes vs cost/benefit between newly approved agents and existing or lower cost agents.

Take it Here

• This course reports to CE broker immediately upon completion.
• Complete all courses at your own pace online.
• Quality and enjoyable courses.
• Modern experience, accessible from any device.
• All courses affordably priced.

Learner Feedback